ArticlePloS one2019

Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies.

Kimiyo N Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.